Embed Size (px)
Citation preview
01 02 03 04
$19.985B
Pfizer
$15.479B
The Roche Group
$13.880B
Merck and Co., Inc.Kenilworth, N.J., U.S.A.
$13.866B
Janssen05
$13.496B
Novartis
06 07 08 09Amgen Gilead Science Novo Nordisk AstraZeneca
10GSK
$13.461B $13.361B $10.206B $8.123B $6.778B
#BestPharmaBrandswww.BestPharmaBrands.com
Best Pharma Brands ranking
The InterbrandHealth Best Pharma Brands global study reveals the biopharma companies that are addressing healthcare professionals’ (HCPs), payers’, and policymakers’ needs. A commitment to brand is a promise to address healthcare challenges and meet the needs of these healthcare professionals.
This is a difficult world for biopharma right now. To be blunt, the industry is misunderstood, and nobody wants to be misunderstood. But, more importantly, the true value of biopharma is being lost, and, for an industry that has such significant contributions to make, that’s unacceptable.
Looking to the future, healthcare professionals desire a commitment to innovative healthcare solutions that go “beyond the pill.” As a result, companies that are adapting their business models, increasing transparency, exploring non-traditional solutions in areas like digital therapies, and ramping up their Corporate Citizenship activities.
Companies that seize the opportunity of leveraging their brands as true assets for their businesses, that get clear about their focus, and express their value, are gaining leadership status.
For general inquiries
Nicole DiamantSenior Manager, Marketing,InterbrandHealthTel US: [email protected]
Change or be changed
“Biopharma is at a pivotal moment, and the time for change is now.”
Jane ParkerCEO, InterbrandHealth
Brand Value Brand Value Brand Value Brand Value Brand Value
Brand Value Brand Value Brand Value Brand Value Brand Value
What is Best Pharma Brands?
At the InterbrandHealth we believe that brands have the power to change the world. And, the Best Pharma Brands exames the changes in the healthcare industry, looking into what value means to healthcare professionals providing an apportunity to change the conversation.
Best Pharma Brands is a Top 10 ranking of global biopharmaceutical brands designed to measure the contribution of the corporate brand to business results. It’s a data-driven, science-driven report for a data-driven, science-driven industry, powered by the opinions of 1,900 healthcare professionals from around the world.
More than a ranking, Best Pharma Brands also offers actionable insights from InterbrandHealth’s proprietary Brand Strength model. Brand Strength can help a company to diagnose its strengths and weaknesses relative to brand performance and steer an enterprise towards using its brand as an asset to drive tangible business growth.
InterbrandHealth® is a registered trademark of Interbrand. All other trademarks appearing herein are trademarks or registered trademarks of their respective owners. Interbrand does not claim ownership of any third-party trademark or image contained herein. Interbrand does not claim to be endorsed by, nor does it endorse any product, business, or trademark contained in this document.
Role of Brand measures that portion of a decision to recommend that can be attributed to the corporate brand, relative to other factors such as: product efficacy and safety, product formulation, other product features, and/or reimbursement. Being able to isolate and quantify the Role of Brand allows us to better measure its impact on the business itself.
Brand valueSingle measure of the brand’s
contribution to business results
Role of BrandInfluence brand has on customer
willingness to recommend
Brand StrengthMeasures brand performance
relative to competition
Financial analysisRoots analysis of brand
in business results
Corporate Role of Brand Local market dynamics play a significant role in the impact of a corporate brand
The Role of Brand in driving recommendation has increased by 57%
The therapuetic category influence
7% 11%
Global US EU China Japan Brazil
10.9%
10.2% 10.4%
9.3%
10.6%
13.6%
13.1%
12.4%
10.4%
9.3%
10.4% 10.2%
Brand Valuation methodology
2013
Corporate Role of Brand*
* Source: IBH 2013 Tracking Study (N = 2,680) * Source: IBH 2015 Best Pharma Brands Study (N = 1,900)
Corporate Role of Brand*
2015
Infectious Diseases
Cardiology Respiratory MetabolicDiseases
Oncology Women’sHealth
